title: Thrombotic risk during pregnancy and puerperium in women with APC-resistance--effective subcutaneous heparin prophylaxis in a pregnant patient.
authors.forename: V
authors.initials: V
authors.lastname: De Stefano
authors.forename: S
authors.initials: S
authors.lastname: Mastrangelo
authors.forename: K
authors.initials: K
authors.lastname: Paciaroni
authors.forename: H
authors.initials: H
authors.lastname: Ireland
authors.forename: D A
authors.initials: DA
authors.lastname: Lane
authors.forename: P
authors.initials: P
authors.lastname: Scirpa
authors.forename: B
authors.initials: B
authors.lastname: Bizzi
authors.forename: G
authors.initials: G
authors.lastname: Leone
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D005166:Factor V Deficiency / Q000150:complications*; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D008875:Middle Aged; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D011256:Pregnancy Outcome / Q000453:epidemiology; D015995:Prevalence; D011486:Protein C / Q000502:physiology*; D011644:Puerperal Disorders / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D012008:Recurrence; D012306:Risk; D013924:Thrombophlebitis / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D011486:Protein C; D006493:Heparin